Home
 /
Papers
 /
Systems Biology
 /
nanoPhos enables ultra-sensitive and cell-type resolved spatial phosphoproteomics
Preprint
Open access
Top 1% · Validated by QED

nanoPhos enables ultra-sensitive and cell-type resolved spatial phosphoproteomics

Denys Oliinyk, Tim Heymann, Lukas Henneberg +13 more
December 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.05.29.656770
99
%
QED Score
QED Impressions

nanoPhos breaks the sensitivity barrier in phosphoproteomics — profiling 4,000+ phosphosites from just 10 ng input — and, integrated with Deep Visual Proteomics, resolves cell-type-specific signaling networks directly within intact tissue sections.

Run full QED analysis
Read paper
Save

QED claims analysis

Summary

nanoPhos achieves nanogram-scale phosphoproteomics through loss-less solid phase extraction and zero-dead-volume enrichment, identifying over 57,000 phosphosites from 1 μg input with >90% quantitative precision, and when integrated with Deep Visual Proteomics enables cell-type-resolved spatial phosphoproteomics that captures over 13,000 phosphosites from 1,000 laser-microdissected neuronal shapes, revealing distinct signaling signatures across neuronal populations and brain regions.

See full analysis
Main Claim 1 –

nanoPhos Enables Nanogram Phosphoproteomics via SPEC and Zero-Dead-Volume Enrichment

Main Claim 2 –

nanoPhos Identifies 57,000+ Phosphosites from 1 µg with 92% R²

Supporting evidence

  • nanoPhos Profiles 100 FACS-Sorted Cells with ~10,000 Phosphosites
  • nanoPhos Profiles Fresh-Frozen and FFPE Tissues with Preserved Pathways
Main Claim 3 –

nanoPhos-DVP Enables Spatial, Cell-Type Phosphoproteomics with 13,000 Phosphosites

Abstract

Mass spectrometry (MS)-based phosphoproteomics has transformed our understanding of cell signaling, yet current workflows face limitations in sensitivity and spatial resolution at sub-microgram inputs. Here, we present nanoPhos, a robust method that extends phosphoproteomics to nanogram scale, making it compatible with cell-type-resolved spatial analysis. It employs loss-less solid phase extraction capture (SPEC) for sample preparation, followed by automated phosphopeptide enrichment using Fe(III)-NTA cartridges. nanoPhos identifies over 57,000 unique phosphorylation sites from 1 µg cell lysate and over 4,000 from only 10 ng, a hundred-fold improvement from recent protocols. Combined with Deep Visual Proteomics (DVP), it enables region- and cell-type resolved phosphoproteomics of mouse brain tissue with spatial fidelity and a depth of 13,000 phosphosites from only 1000 cell shapes. This establishes nanoPhos as a versatile and ultra-sensitive platform that extends DVP to post-translational modifications and opens up for cell-type-specific signaling analysis in intact tissue.

Related papers

How the QED Score works

QED Score is an AI-based quality metric for life science research. It rates each paper on two dimensions: originality (is the finding new and important?) and validity (does the evidence support the claims?). Author names and affiliations are removed before scoring. Each manuscript is broken down into its claims and the experiments behind them, and specialized AI agents then examine those claims for statistical rigor, consistency across figures, and contradictions with the existing literature. A verification layer re-checks every issue they flag. Scores are percentile ranks against all papers in the corpus. In a blinded study of papers where QED Score and journal rank disagreed, domain experts sided with QED Score in 75% of cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?